Visualizing how cancer drugs reshape proteins linked to lung cancer

Researchers at Nano Life Science Institute (WPI-NanoLSI) and the Cancer Research Institute at Kanazawa University have ...
EurekAlert!

Structure-based development of potent and selective type-II kinase inhibitors of RIPK1

This new article publication from Acta Pharmaceutica Sinica B, discusses the structure-based development of potent and selective type-II kinase inhibitors of RIPK1. Receptor-interacting ...
GEN

Structure of Key Parkinson’s Disease Protein, PINK1, Seen for First Time

Scientists at Walter and Elizabeth Hall Institute (WEHI) have made what they describe as a huge leap forward in the fight against Parkinson’s disease, solving a decades-long mystery by determining the ...
Technology Networks

Scientists Uncover New Clues on Lung Cancer Treatment Resistance

Researchers visualized ALK fusion proteins in real time. They showed that ALK inhibitors reshape flexible protein regions to ...
The Scientist

The Journey to a Nobel Prize: A Protein Design and Structure Research Timeline

In the wee hours of an October morning, David Baker, a protein biologist at the University of Washington (UW), received the most-awaited phone call in a scientist’s career. Halfway around the world, ...

Kanazawa University research: Visualizing how cancer drugs reshape proteins linked to lung cancer

Researchers at Nano Life Science Institute (WPI-NanoLSI) and the Cancer Research Institute at Kanazawa University led have uncovered how targeted lung cancer drugs alter the shape and behavior of a ...